Tag: trends

DELRAY BEACH, Fla., June 17, 2026 /PRNewswire/ -- According to MarketsandMarkets, "Industrial Lubricants Market by Base Oil (Mineral Oil, Synthetic Oil, Bio-based Oil), Product Type...

DELRAY BEACH, Fla., June 17, 2026 /PRNewswire/ -- According to MarketsandMarkets, "Industrial Lubricants Market by Base Oil (Mineral Oil, Synthetic Oil, Bio-based Oil), Product Type...

TOKYO, June 17, 2026 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., will participate...

Advancing transparency and responsible journal evaluationLONDON, June 17, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced...

Enhances portfolio, high grades capital allocation, lowers costs and enhances liquidity

Enhances portfolio, high grades capital allocation, lowers costs and enhances liquidity

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global GLP-1 Receptor Agonist Market size & share revenue was valued at approximately USD 28.7 Billion in 2025 and is expected to reach USD 34.2 Billion in 2026 and is expected to reach around USD 95.3 Billion by 2035, at a CAGR of 12.1% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Pfizer Inc., Merck & Co. Inc., Zealand Pharma A/S, Hanmi Pharmaceutical Co. Ltd. and others.

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global GLP-1 Receptor Agonist Market size & share revenue was valued at approximately USD 28.7 Billion in 2025 and is expected to reach USD 34.2 Billion in 2026 and is expected to reach around USD 95.3 Billion by 2035, at a CAGR of 12.1% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Pfizer Inc., Merck & Co. Inc., Zealand Pharma A/S, Hanmi Pharmaceutical Co. Ltd. and others.

Net revenues from retail stores up 2.9% on lower store count MONTREAL, June 16, 2026 /CNW/ - Reitmans (Canada) Limited ("RCL" or the "Company")...

Alongside, by TimelyCare, analyzes 1 million+ student interactions to reveal critical trends in belonging, motivation, and attendance

Alongside, by TimelyCare, analyzes 1 million+ student interactions to reveal critical trends in belonging, motivation, and attendance

Industry leaders to explore how hyperscalers, data center providers, and neocloud companies are reshaping the digital infrastructure landscape to meet accelerating AI demandBOSTON and...

HILLSBOROUGH, N.C., June 16, 2026 /PRNewswire/ -- In honor of National Sex Education Month and as part of its expanding commitment to sexual health...

Issued on behalf of MindWalk Holdings Corp.Everyone is racing to point powerful AI models at drug discovery. A growing camp argues the real prize...

NASDAQ: EUTSXV: EUwww.encoreuranium.comDALLAS, June 16, 2026 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy CompanyTM, reports positive...

OTTAWA, Ontario, June 16, 2026 (GLOBE NEWSWIRE) -- The number of home sales recorded over Canadian MLS® Systems increased 5.5% on a month-over-month basis in May 2026.

ABU DHABI, UAE, June 16, 2026 /PRNewswire/ -- Agthia Group PJSC, the region's leading food and beverage company, today announced the launch of Fuell, the...